Stifel lowered the firm’s price target on Patterson-UTI (PTEN) to $10 from $12 and keeps a Buy rating on the shares. In line Q2 results and Q3 guidance highlight the resiliency of Patterson’s “high-quality equipment despite persistent headwinds,” the analyst tells investors. The firm continues to view the risk/reward as favorable, but is reducing its 2026 forecast to reflect uncertainty and lowering its price target based on a revised sum-of-the-parts analysis.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTEN:
- Patterson-UTI price target lowered to $8.50 from $9 at RBC Capital
- Patterson-UTI Energy Reports Q2 2025 Financial Results
- Patterson-UTI Energy Navigates Challenges with Optimism
- Patterson-UTI: Strong Financial Performance and Promising Outlook Support Buy Rating
- Patterson-UTI Reports Q2 2025 Net Loss Amid Impairment